Refine
Has Fulltext
- yes (17)
Is part of the Bibliography
- yes (17)
Year of publication
Document Type
- Journal article (17)
Language
- English (17)
Keywords
- CRMO (3)
- inflammation (3)
- CNO (2)
- DIRA (2)
- IL-10 (2)
- Medizin (2)
- PAPA (2)
- TLR4 (2)
- TNF-α (2)
- bone (2)
- chronic non-bacterial osteomyelitis (2)
- chronic nonbacterial osteomyelitis (2)
- chronic recurrent multifocal osteomyelitis (2)
- deficiency (2)
- juvenile idiopathic arthritis (2)
- medicine (2)
- treatment (2)
- ACP5 (1)
- AD-AID (1)
- AICDA (1)
- AID-ΔE4a (1)
- Age (1)
- Antibody (1)
- B cells (1)
- CVID (1)
- England (1)
- European Society for Immunodeficiencies (ESID) (1)
- German PID-NET registry (1)
- HRQOL (1)
- Hemagglutination inhibition (1)
- IL-10 expression (1)
- IL-12B (1)
- IL-12p40 (1)
- IL12B (1)
- IgG substitution therapy (1)
- Immunogenicity (1)
- Majeed (1)
- Majeed-Syndrome (1)
- Mikrobiologie (1)
- PAPA syndrome (1)
- PID prevalence (1)
- Prevalence (1)
- Risk (1)
- Safety (1)
- Vaccine (1)
- Varizellen-Virus (1)
- Viruses (1)
- alkaline phosphatase (1)
- antinuclear antibodies (1)
- asfotase alfa (1)
- autoimmunity (1)
- autoinflammation (1)
- biomarker (1)
- bisphosphonate treatment (1)
- bone autoinflammation (1)
- cells (1)
- cerebral calcification (1)
- children (1)
- cidofovir (1)
- congenital dyserythropoietic anemia (1)
- cytokine (1)
- diagnosis (1)
- disease (1)
- double negative B cells (1)
- dysplasia (1)
- expression (1)
- gene (1)
- hyper-IgM syndrome type 2 (HIGM2) (1)
- hypertrophic osteodystrophy (1)
- hypophosphatasia (1)
- immunodeficiency (1)
- lymphoplasmacellular osteomyelitis (1)
- mutational targeting (1)
- osteomalacia (1)
- pediatric patients (1)
- pediatrics (1)
- physical activity (1)
- polymorphism (1)
- primary immunodeficiency (PID) (1)
- promoter (1)
- rare bone disease (1)
- registry for primary immunodeficiency (1)
- resistant acid phosphatase (1)
- rickets (1)
- serum (1)
- somatic hypermutation (1)
- spondyloenchondrodysplasia (1)
- synovial fluid (1)
- systemic lupus erythematosus (1)
- trap (1)
- type I interferonopathy (1)
- varicella-zoster virus immunosuppression (1)
Institute
- Kinderklinik und Poliklinik (14)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (3)
- Institut für Hygiene und Mikrobiologie (1)
- Lehrstuhl für Orthopädie (1)
- Medizinische Klinik und Poliklinik II (1)
- Neurochirurgische Klinik und Poliklinik (1)
- Pathologisches Institut (1)
Hyper-IgM syndrome type 2 (HIGM2) is a B cell intrinsic primary immunodeficiency caused by mutations in AICDA encoding activation-induced cytidine deaminase (AID) which impair immunoglobulin class switch recombination (CSR) and somatic hypermutation (SHM). Whereas autosomal-recessive AID-deficiency (AR-AID) affects both CSR and SHM, the autosomal-dominant form (AD-AID) due to C-terminal heterozygous variants completely abolishes CSR but only partially affects SHM. AR-AID patients display enhanced germinal center (GC) reactions and autoimmune manifestations, which are not present in AD-AID, suggesting that SHM but not CSR regulates GC reactions and peripheral B cell tolerance. Herein, we describe two siblings with HIGM2 due to a novel homozygous AICDA mutation (c.428-1G > T) which disrupts the splice acceptor site of exon 4 and results in the sole expression of a truncated AID variant that lacks 10 highly conserved amino acids encoded by exon 4 (AID-ΔE4a). AID-ΔE4a patients suffered from defective CSR and enhanced GC reactions and were therefore indistinguishable from other AR-AID patients. However, the AID-ΔE4a variant only partially affected SHM as observed in AD-AID patients. In addition, AID-ΔE4a but not AD-AID patients revealed impaired targeting of mutational hotspot motives and distorted mutational patterns. Hence, qualitative defects in AID function and altered SHM rather than global decreased SHM activity may account for the disease phenotype in these patients.